72
Participants
Start Date
April 30, 2009
Primary Completion Date
March 31, 2012
Study Completion Date
March 31, 2012
Candesartan
Candesartan cilexitil tablets, 16 mg once daily
propranolol
Propranolol hydrochloride capsules 160 mg once daily, slow release formulation
placebo
placebo tablets and capsules
Norwegian National Headache Centre, St. Olavs University Hospital, Trondheim
Collaborators (1)
AstraZeneca
INDUSTRY
St. Olavs Hospital
OTHER
Kragerø Tablettproduksjon as, Norway
UNKNOWN
Norwegian University of Science and Technology
OTHER